Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-10-05 4:01 pm Purchase | 2026-09-28 | 13G | OBSIDIAN THERAPEUTICS INC OBX | Paradigm BioCapital Advisors LP | 4,101,576 6.600% | 4,101,576 (New Position) | Filing History |
| 2026-10-01 4:05 pm Purchase | 2026-09-24 | 13G | SPYRE THERAPEUTICS, INC SYRE | Paradigm BioCapital Advisors LP | 4,457,450 5.100% | 4,457,450 (New Position) | Filing History |
| 2026-09-17 4:06 pm Purchase | 2026-09-10 | 13G | TYRA BIOSCIENCES INC TYRA | Paradigm BioCapital Advisors LP | 3,473,453 5.800% | 3,473,453 (New Position) | Filing History |
| 2026-08-14 4:23 pm Sale | 2026-06-30 | 13G | ARCELLX INC ACLX | Paradigm BioCapital Advisors LP | 0 0.000% | -5,724,016 (Position Closed) | Filing History |
| 2026-08-14 4:23 pm Purchase | 2026-06-30 | 13G | ASSEMBLY BIOSCIENCES INC N ASMB | Paradigm BioCapital Advisors LP | 1,553,748 7.800% | 688,497 (+79.57%) | Filing History |
| 2026-08-14 4:22 pm Purchase | 2026-06-30 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm BioCapital Advisors LP | 6,723,788 6.100% | 1,090,000 (+19.35%) | Filing History |
| 2026-08-14 4:22 pm Sale | 2026-06-30 | 13G | LEXEO THERAPEUTICS INC LXEO | Paradigm BioCapital Advisors LP | 4,175,382 5.300% | -2,008,752 (-32.48%) | Filing History |
| 2026-08-14 4:22 pm Purchase | 2026-06-30 | 13G | EDGEWISE THERAPEUTICS INC EWTX | Paradigm BioCapital Advisors LP | 10,215,455 9.500% | 3,674,245 (+56.17%) | Filing History |
| 2026-08-14 4:21 pm Sale | 2026-06-30 | 13G | MAZE THERAPEUTICS INC MAZE | Paradigm BioCapital Advisors LP | 0 0.000% | -3,051,087 (Position Closed) | Filing History |
| 2026-07-17 4:05 pm Purchase | 2026-07-10 | 13G | JADE BIOSCIENCES, INC. JBIO | Paradigm BioCapital Advisors LP | 3,106,793 5.100% | 3,106,793 (New Position) | Filing History |
| 2026-06-26 4:05 pm Purchase | 2026-06-18 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Paradigm BioCapital Advisors LP | 5,633,788 5.100% | 2,124,535 (+60.54%) | Filing History |
| 2026-06-24 4:05 pm Purchase | 2026-06-16 | 13G | MBX BIOSCIENCES INC MBX | Paradigm BioCapital Advisors LP | 2,493,015 5.200% | 2,493,015 (New Position) | Filing History |
| 2026-05-15 4:26 pm Sale | 2026-03-31 | 13G | EYEPOINT INC EYPT | Paradigm BioCapital Advisors LP | 3,142,437 3.800% | -1,049,824 (-25.04%) | Filing History |
| 2026-05-15 4:25 pm Sale | 2026-03-31 | 13G | UROGEN PHARMA LTD URGN | Paradigm BioCapital Advisors LP | 1,703,949 3.500% | -2,512,135 (-59.58%) | Filing History |
| 2026-05-15 4:25 pm Purchase | 2026-03-31 | 13G | LEXEO THERAPEUTICS INC LXEO | Paradigm BioCapital Advisors LP | 6,184,134 8.300% | 1,420,936 (+29.83%) | Filing History |
| 2026-05-15 4:25 pm Sale | 2026-03-31 | 13G | ERASCA INC ERAS | Paradigm BioCapital Advisors LP | 10,392,702 3.300% | -4,766,393 (-31.44%) | Filing History |
| 2026-05-11 4:02 pm Purchase | 2026-05-04 | 13G | ASSEMBLY BIOSCIENCES INC N ASMB | Paradigm BioCapital Advisors LP | 865,251 5.400% | 865,251 (New Position) | Filing History |
| 2026-04-24 8:12 pm Purchase | 2026-04-17 | 13G | ACHIEVE LIFE SCIENCES INC ACHV | Paradigm BioCapital Advisors LP | 9,903,712 9.200% | 9,903,712 (New Position) | Filing History |
| 2026-04-01 4:00 pm Purchase | 2026-03-25 | 13G | MAZE THERAPEUTICS INC MAZE | Paradigm BioCapital Advisors LP | 3,051,087 6.100% | 3,051,087 (New Position) | Filing History |
| 2026-02-24 4:00 pm Purchase | 2026-02-17 | 13G | EYEPOINT INC EYPT | Paradigm BioCapital Advisors LP | 4,192,261 5.100% | 4,192,261 (New Position) | Filing History |